Dr. Reddy's Laboratories Ltd. closed 17.18% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Under the agreement, Dr Reddy's will have exclusive rights from SHIPL to promote and distribute Beyfortus within the country ...

Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant Sanofi’s Indian ...

The company plans to introduce Beyfortus, which contains the monoclonal antibody, nirsevimab, in a prefilled injection used ...

The company plans to introduce Beyfortus, which contains the monoclonal antibody nirsevimab, in a prefilled injection used ...

Apollo Hospitals, founded by Dr Prathap Chandra Reddy, is India's largest private healthcare network with 73 hospitals, ...

Uncertainties around US tariffs and the end of the limited competition period for generic Revlimid in the US will loom in ...

Dr. Reddy’s Laboratories will expand its partnership with Sanofi Healthcare India (SHIPL) by launching the latter’s novel drug Beyfortus (nirsevimab) in India.

Shares of Bajaj Finance, Bajaj Finserv, Trent, Ambuja, BPCL, and NTPC Green are likely to be in the focus as these companies ...

HYDERABAD: Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant Sanofi’s Indian arm, Sanofi Healthcare India Pvt Ltd (SHIPL), to bring a ...

VIJAYAWADA: Former Defence Research and Development Organisation (DRDO) Chairman Dr G Satish Reddy officially assumed charge ...